DMSA

DRUG3 trials

Sponsors

National Institute of Mental Health (NIMH), Second Affiliated Hospital, School of Medicine, Zhejiang University, M.D. Anderson Cancer Center

Conditions

Acute Myeloid Leukemia (AML)Asperger's DisorderAutismChild Development Disorders, PervasiveWilson's Disease

Early Phase 1

The Individual Therapy for Patients With Wilson's Disease

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityWilson's Disease

Start: 2019-03-15End: 2024-12-31Target: 400Updated: 2019-05-21

Phase 2

Mercury Chelation to Treat Autism

WithdrawnNCT00376194

National Institute of Mental Health (NIMH)Asperger's Disorder, Autism, Child Development Disorders, Pervasive

Start: 2006-09-30End: 2007-03-31Updated: 2013-09-18

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

RecruitingNCT06811233

M.D. Anderson Cancer CenterAcute Myeloid Leukemia (AML)

Start: 2025-05-08End: 2031-08-31Target: 140Updated: 2025-10-24